EP4728093A1 - Assays zur analyse von ribonukleinsäure (rna)-molekülen - Google Patents
Assays zur analyse von ribonukleinsäure (rna)-molekülenInfo
- Publication number
- EP4728093A1 EP4728093A1 EP24740291.0A EP24740291A EP4728093A1 EP 4728093 A1 EP4728093 A1 EP 4728093A1 EP 24740291 A EP24740291 A EP 24740291A EP 4728093 A1 EP4728093 A1 EP 4728093A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- rna molecule
- rna
- sample
- oligonucleotide
- molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363472686P | 2023-06-13 | 2023-06-13 | |
| PCT/US2024/033854 WO2024259135A1 (en) | 2023-06-13 | 2024-06-13 | Assays for analysis of ribonucleic acid (rna) molecules |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP4728093A1 true EP4728093A1 (de) | 2026-04-22 |
Family
ID=91856269
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP24740291.0A Pending EP4728093A1 (de) | 2023-06-13 | 2024-06-13 | Assays zur analyse von ribonukleinsäure (rna)-molekülen |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP4728093A1 (de) |
| WO (1) | WO2024259135A1 (de) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT3401400T (lt) | 2012-05-25 | 2019-06-10 | The Regents Of The University Of California | Būdai ir kompozicijos, skirtos rnr molekulės nukreipiamai tikslinės dnr modifikacijai ir rnr molekulės nukreipiamam transkripcijos moduliavimui |
| WO2014085568A2 (en) * | 2012-11-27 | 2014-06-05 | Saint Louis University | Hbv rnase h purification and enzyme inhbitors |
| US20140310830A1 (en) | 2012-12-12 | 2014-10-16 | Feng Zhang | CRISPR-Cas Nickase Systems, Methods And Compositions For Sequence Manipulation in Eukaryotes |
| EP3169309B1 (de) | 2014-07-16 | 2023-05-10 | Novartis AG | Verfahren zur verkapselung einer nukleinsäure in einem lipidnanopartikelhost |
| SI3436077T1 (sl) | 2016-03-30 | 2025-07-31 | Intellia Therapeutics, Inc. | Formulacije lipidnih nanodelcev za komponente crispr/cas |
| FI3688162T3 (fi) | 2017-09-29 | 2024-05-15 | Intellia Therapeutics Inc | Formulaatioita |
| BR112020005287A2 (pt) | 2017-09-29 | 2020-09-24 | Intellia Therapeutics, Inc. | composições e métodos para edição de gene ttr e tratar amiloidose attr |
| CA3135726A1 (en) | 2019-05-03 | 2020-11-12 | Francis Barany | Markers for identifying and quantifying of nucleic acid sequence mutation, expression, splice variant, translocation, copy number, or methylation changes |
| US20220220552A1 (en) | 2020-04-20 | 2022-07-14 | New York Institute Of Technology | Methods for direct sequencing of rna |
| US20240327933A1 (en) * | 2020-12-16 | 2024-10-03 | The Broad Institute, Inc. | Coronavirus rapid diagnostics |
-
2024
- 2024-06-13 EP EP24740291.0A patent/EP4728093A1/de active Pending
- 2024-06-13 WO PCT/US2024/033854 patent/WO2024259135A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2024259135A1 (en) | 2024-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230203480A1 (en) | Lipid nanoparticle formulations for crispr/cas components | |
| Strobel et al. | Double strand cleavage of genomic DNA at a single site by triple helix formation | |
| EP4385514A2 (de) | Formulierungen | |
| KR20220070443A (ko) | 반복성 dna와 연관된 장애의 치료용 조성물 및 방법 | |
| KR20240021170A (ko) | 변형된 mRNA, 변형된 비-코딩 RNA, 및 그의 용도 | |
| Le et al. | Evaluation of anhydrohexitol nucleic acid, cyclohexenyl nucleic acid and d-altritol nucleic acid-modified 2′-O-methyl RNA mixmer antisense oligonucleotides for exon skipping in vitro | |
| CA3222745A1 (en) | Modified guide rnas comprising an internal linker for gene editing | |
| EP3469084A1 (de) | Hochspezifische genomeditierung durch chemisch modifizierte guide-rnas | |
| JP2010525813A (ja) | 二本鎖rnaによる遺伝子発現の特異的阻害のための、方法及び組成物 | |
| WO2016112963A1 (en) | Delivery of biomolecules into cells | |
| US20150315581A1 (en) | Signal activatable constructs and related components compositions methods and systems | |
| CN114269921A (zh) | TREM组合物用以调节tRNA池的用途 | |
| JP2024538168A5 (de) | ||
| US20220002796A1 (en) | Quality control of lna oligonucleotide therapeutics using massively parallel sequencing | |
| WO2024259135A1 (en) | Assays for analysis of ribonucleic acid (rna) molecules | |
| US20200255836A1 (en) | Nucleic acid aptamer for inhibiting activity of genome-editing enzyme | |
| EP3858989A1 (de) | Alkalische phosphatasezusammensetzung und herstellungsverfahren für dephosphorylierte nukleinsäure und markierte nukleinsäure | |
| EP3858988A1 (de) | Alkalische phosphatasezusammensetzung, verfahren zur herstellung dephosphorylierter nukleinsäure und verfahren zur herstellung von markierter nukleinsäure | |
| EP3665306B1 (de) | Verfahren zur rna identifizierung durch rnase h verdaung und grösse trennung | |
| WO2022182959A1 (en) | Compositions and methods for treatment of myotonic dystrophy type 1 with crispr/slucas9 | |
| Saei et al. | 5-Triazolyl uracil improves nucleobase stacking, pyrimidine recognition, biological activity, and specificity of RNA-binding triplex-forming peptide nucleic acids | |
| Giannakopoulos et al. | Translation‐Promoting Effects of RNA Template Overhangs in the Absence of Ribosomes | |
| US20240425850A1 (en) | Noncanonical crRNA for Highly Efficient Genome Editing | |
| Yeşiltaç-Tosun | Chemical and enzymatic strategies for RNA modification analysis by oligonucleotide mass spectrometry | |
| US20240344059A1 (en) | Gene Editing of Regulatory Elements |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20260112 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR |